2015 L6 Case 5 Car Crash Guy
Overview of Blood Groups and Physiology
Discussion focused on blood groups and the physiological principles behind blood transfusion protocols.
Case study of a patient experiencing severe blood loss after a traumatic incident in a car crash.
Blood Loss and its Implications
Patient characteristics: young male who is unconscious and has lost 40% of total blood volume.
Resulting hypotension and increased risk of hypovolemic shock due to significant blood loss
Hypovolemic Shock: Inefficient delivery of oxygenated blood to organs, risking organ failure.
Lack of patient identification complicates treatment and risk assessment, especially regarding previous transfusions and allergies.
Risks of Blood Transfusion
Blood transfusions are routine but not without risks; transferring human tissue imposes potential hazards.
Internal injuries from trauma can lead to electrolyte imbalances, possibly affecting central nervous system function.
Spleen Damage: Highly vascular organ crucial for red blood cell quality control; trauma can lead to heavy internal bleeding.
Disseminated Intravascular Coagulation (DIC): Potential condition where a cascade of clotting occurs throughout the body, resulting in small clots and post-clotting bleeding risk.
DIC can lead to severe hemorrhaging after initial clotting reactions.
Initial Patient Management
Focus on hemodynamic stability: stem blood loss and restore blood volume.
Trauma Response Protocol: Multi-pronged approach including:
Administering agents to promote clotting (e.g., tranexamic acid, fresh frozen plasma).
Administering saline for volume restoration to increase blood pressure, especially critical during acute emergencies.
Packed Red Cells: Used sparingly; only when oxygen delivery is compromised due to lost hemoglobin capacity.
Tranexamic Acid
Tranexamic acid is an antifibrinolytic agent that inhibits plasminogen activation, helping to stabilize clots.
Used in various scenarios, including postpartum hemorrhage and trauma.
Components of Blood Transfusion
In the UK, blood transfusions typically involve packed red cells, not whole blood.
Blood donation leads to fractionation into components (red cells, plasma, and platelets).
White blood cells are typically discarded due to risk of immune reactions.
Blood Composition and Measurement
Average adult has about 5 liters of blood with distinct components:
Plasma (over half), red blood cells (just under half), and very small amounts of platelets and white blood cells.
Specific transfusion criteria:
Blood transfusion considered when over a third of blood volume is lost or hemoglobin levels drop below 80 g/L.
Historical Context
Blood group discovery by Karl Landsteiner in 1901 (ABO system) essential for safe transfusions.
Early blood transfusions were carried out with minimal understanding, leading to fatalities.
Blood banking practices evolved significantly during wartime, leading to modern systems of blood storage and transfusion.
ABO Blood Group System
Comprises four primary groups: A, B, AB, and O based on antigen presence on red blood cells.
Genetic Inheritance: Dominant and recessive alleles govern blood group formation.
Rh Factor: Presence of D antigen significantly impacts transfusion compatibility.
Blood Group Compatibility Table
Summary of blood type compatibility for transfusion:
A: Can receive A and O
B: Can receive B and O
AB: Universal recipient (A, B, AB, O)
O: Universal donor, but can only receive O
Rh positive individuals can receive Rh negative blood, while Rh negative individuals can only receive Rh negative blood.
Patient Testing and Safety Procedures
Blood typing involves both forward (antigens) and reverse (antibodies) group testing.
A rigorous process is necessary to prevent transfusion reactions.
Transfusion Reactions Risks and Management
Acute hemolytic transfusion reactions can occur if antibodies react with mismatched blood.
Symptoms include hematuria, fever, and potential acute kidney injury. Early detection is critical for patient safety.
Vigilant monitoring is required throughout the transfusion process.
Plasma Products and Emerging Techniques
Plasma provides essential coagulation factors; procurement influenced by historical issues (HIV, hepatitis transmissions in the '70s and '80s).
Recent innovations aim to ensure blood supply integrity and safety for patients, including matching donor and recipient factors.
Challenges in plasma safety continue with prion disease risks affecting donor eligibility criteria.
Conclusion
Continuous education and public health initiatives are critical to maintaining adequate blood supplies, especially across diverse populations.
The evolution of blood transfusion protocols demonstrates an ongoing commitment to patient safety and care.